P143: Rates of pathological complete response to neoadjuvant pertuzamab in patients with HER2 positive breast cancer
2020 ◽
Vol 46
(6)
◽
pp. e48-e49
2017 ◽
2017 ◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 509-509
◽